Anti-SARS-CoV-2 S Protein Monoclonal Antibody MW33

Preferred Label : Anti-SARS-CoV-2 S Protein Monoclonal Antibody MW33;

NCIt definition : A recombinant, human immunoglobulin G1 (IgG1) kappa monoclonal antibody directed against the spike (S) protein of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), that can potentially be used for immunization against the Coronavirus disease 2019 (COVID-19). Upon administration, anti-SARS-CoV-2 S protein monoclonal antibody MW33 specifically targets and binds to the receptor-binding domain (RBD) of S protein, thereby blocking viral attachment and entry into human cells and may thereby neutralize SARS-CoV-2. This may slow the progression of the disease and accelerate recovery, and may potentially provide temporary protection against infection with SARS-CoV-2.;

Molecule name : MW 33; MW-33;

NCI Metathesaurus CUI : CL1770968;

Details

Origin ID

C182632;

UMLS CUI

C5432250;

Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
chemical_or_drug_has_mechanism_of_action
- Antigen Binding [NCIt concept]
concept_is_in_subset
- NCIt COVID-19 Agent Terminology [NCIt concept]
- NCIt COVID-19 Terminology [NCIt concept]
has_target
- SARS-CoV-2 Spike Glycoprotein [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients